WASHINGTON, June 21, 2007 /PRNewswire-USNewswire/ -- The following was released today by APIC:
WHAT: -- First nationwide study of the prevalence of Methicillin-resistant Staphylococcus aureus (MRSA), a virulent multi-drug resistant organism, in U.S. healthcare facilities. -- MRSA prevalence study findings significantly exceed previous estimates and will for the first time provide a picture of the threat MRSA poses to patients in facilities caring for virtually every type of patient, including acute care, cancer, cardiac, pediatric, rehabilitation and long-term care. -- The study, funded by the Association for Professionals in Infection Control and Epidemiology (APIC), collected data from more than 1,200 healthcare facilities in all 50 states to determine the current magnitude of MRSA. -- Results and implications from the study on MRSA will be discussed at APIC's 34th Annual Conference & International Meeting. WHEN/WHERE: 12:00 p.m. Eastern, 9:00 a.m. Pacific, Tuesday, June 26, 2007 San Jose, CA Marriott, Guadalupe Room 301 South Market Street (Directions, http://www.apic.org/scriptcontent/custom/sites/ac2007/index.cfm) or Media call-in connection: 800-308-9694, enter 400179 For study results, please go to: http://www.apic.org/MRSAStudy (link will be live at 12:01 am, 6/25/07) WHY: -- In 1972, MRSA accounted for only two percent of all Staphylococcus aureus healthcare-associated infections (HAIs) reported to the Centers for Disease Control and Prevention (CDC). Today, MRSA accounts for more than 60 percent of Staphylococcus aureus infections. -- The MRSA death rate has been estimated to be more than 2.5 times higher than infections from Staphylococcus aureus that are susceptible to methicillin. -- While there are a few national MRSA estimates, these are limited in scope and size, and therefore, the true magnitude of the total burden of MRSA in the U.S. healthcare population is unknown. WHO: -- Kathy Warye -- Chief Executive Officer, APIC -- Denise Murphy, RN, MPH, CIC -- 2007 APIC President -- William Jarvis, M.D. -- President, Jason and Jarvis Associates CONTACT: Journalists wishing to participate in the press briefing in person or via telephone and/or arrange interviews please call Jonathan Osmundsen at 202-261-2869, email: .Jonathan.Osmundsen@mslpr.com
CONTACT: Jonathan Osmundsen, +1-202-261-2869,, for APIC Jonathan.Osmundsen@mslpr.com
Web site: http://www.apic.org/
Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company